ANI Pharmaceuticals launches Etodolac 300mg oral capsules ANI Pharmaceuticals.

The US market for Etodolac 300mg capsules totals $9 million on a trailing 12 month basis, per IMS Health. Ahead of today's announcement, only two companies marketed the merchandise. Arthur S. Przybyl, President and Chief Executive Officer said, ‘We are very happy to announce the launch of our second product from the portfolio of approved generic products we acquired from Teva in January 2014.’.. ANI Pharmaceuticals launches Etodolac 300mg oral capsules ANI Pharmaceuticals, Inc.Now, there’s a plan to mark the history of this devastating weapon. Researchers from the National Malignancy Institute are studying previous and present cancer instances in New Mexico that might be related to the test. It’s not about anti-nuclear protests, stated Cordova, a cancer survivor. We wish recognition from the U.S. Government that they did this to us, that they emerged here and do this test. And that they walked aside and still left us for 70 years to deal with it on our own. Vera Burnett-Powell, a spokeswoman for the U.S. Department of Justice’s Radiation Publicity Compensation Act program, didn’t immediately return a phone message and email from The Associated Press.